Evidence map›Paper›PMID 34990292›Full record

ArticleJCO oncology practice2022

Impact of COVID-19 on Hematology-Oncology Trainees: A Quantitative and Qualitative Assessment.

Urshila Durani, Ajay Major, Ana I Velazquez, Jori May, Marquita Nelson, Ze Zheng, Anurekha G Hall, Sara Taveras Alam, Robby Reynolds, J Colton Thompson and 8 more

Open access · hybridAbstract read
In one paragraph

Article in JCO oncology practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 15 institutions in 1 country.

Urshila DuraniDepartment of Hematology and HCT, City of Hope, Duarte, CA.ORCID 0000-0003-1860-2424
Ajay MajorSection of Hematology-Oncology, Department of Medicine, The University of Chicago, Chicago, IL.ORCID 0000-0001-7261-1335
Ana I VelazquezDivision of Hematology-Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA.ORCID 0000-0002-6153-5557
Jori MayDivision of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham Medical Center, Birmingham, AL.ORCID 0000-0001-7744-5700
Marquita NelsonDivision of Hematology and Oncology, Department of Medicine, University of Tennessee Health Science Center, Memphis, TN.
Ze ZhengDivision of Endocrinology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.ORCID 0000-0002-4453-224X
Anurekha G HallDivision of Hematology and Oncology, Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA.
Sara Taveras AlamDivision of Hematology and Oncology, Baylor College of Medicine, Houston, TX.ORCID 0000-0002-4099-3073
Robby ReynoldsAmerican Society of Hematology, Washington, DC.
J Colton ThompsonAmerican Society of Hematology, Washington, DC.
Ashok KumbamuKern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN.
Devika G DasDivision of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham Medical Center, Birmingham, AL.
Martina C MurphyDivision of Hematology and Oncology, University of Florida, Gainesville, FL.
Elizabeth HenryDepartment of Medical Education, Loyola University Medical Center, Maywood, IL.ORCID 0000-0003-2948-3985
Alfred Ian LeeSection of Hematology, Department of Internal Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT.ORCID 0000-0002-5968-3948
Ariela L MarshallDivision of Hematology, Mayo Clinic, Rochester, MN.ORCID 0000-0001-7388-0422
Ted WunDivision of Hematology and Oncology, University of California Davis School of Medicine, Sacramento, CA.ORCID 0000-0001-6383-7172
Lachelle Dawn WeeksDivision of Hematologic Malignancies, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA.ORCID 0000-0001-8726-6212
American Society of Hematology · USMayo Clinic in Arizona · USUniversity of Alabama at Birmingham · USBaylor College of Medicine · USCity of Hope · USHarvard University · USLoyola University Medical Center · USMedical College of Wisconsin · USSeattle Children's Hospital · USUniversity of California, Davis · USUniversity of California, San Francisco · USUniversity of Chicago · USUniversity of Florida · USUniversity of Tennessee Health Science Center · USYale Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeGraduate medical and research training has drastically changed during the COVID-19 pandemic, with widespread implementation of virtual learning, redeployment from core rotations to the care of patients with COVID-19, and significant emotional and physical stressors. The specific experience of hematology-oncology (HO) fellows during the COVID-19 pandemic is not known.

methodsWe conducted a mixed-methods study using a survey of Likert-style and open-ended questions to assess the training experience and well-being of HO fellows, including both clinical and postdoctoral trainee members of the American Society of Hematology and ASCO.

resultsA total of 2,306 surveys were distributed by e-mail; 548 (23.8%) fellows completed the survey. Nearly 40% of fellows felt that they had not received adequate mental health support during the pandemic, and 22% reported new symptoms of burnout. Pre-existing burnout before the pandemic, COVID-19-related clinical work, and working in a primary research or nonclinical setting were associated with increased burnout on multivariable logistic regression. Qualitative thematic analysis of open-ended responses revealed significant concerns about employment after training completion, perceived variable quality of virtual education and board preparation, loss of clinical opportunities to prepare for independent clinical practice, inadequate grant funding opportunities in part because of shifting research priorities, variable productivity, and mental health or stress during the pandemic.

conclusionHO fellows have been profoundly affected by the pandemic, and our data illustrate multiple avenues for fellowship programs and national organizations to support both clinical and postdoctoral trainees.

Indexed as

Burnout, ProfessionalCOVID-19HematologyEducation, Medical, GraduateHumansMedical OncologyPandemics

Identifiers

PMID34990292
PMCPMC9014488
OpenAlexW4205127695

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.